Health and cost impact of stepping down asthma medication for UK patients, 2001-2017: A population-based observational study.
<h4>Background</h4>Guidelines recommend stepping down asthma treatment to the minimum effective dose to achieve symptom control, prevent adverse side effects, and reduce costs. Limited data exist on asthma prescription patterns in a real-world setting. We aimed to evaluate the appropriat...
Saved in:
| Main Authors: | Chloe I Bloom, Laure de Preux, Aziz Sheikh, Jennifer K Quint |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2020-07-01
|
| Series: | PLoS Medicine |
| Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003145&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physicians’ attitudes towards step-down asthma treatment in Turkey: a nationwide perspective
by: Müge Erbay, et al.
Published: (2025-12-01) -
Impact of COPD and asthma on in-hospital mortality and management of patients with heart failure in England and Wales: an observational analysis
by: Claudia Gulea, et al.
Published: (2022-06-01) -
Cost–consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK
by: Jennifer K Quint, et al.
Published: (2022-06-01) -
Comparison of ICS dose reduction vs. montelukast discontinuation for step-down therapy in well-controlled asthma: a pilot randomized controlled trial
by: Besharat Rahimi, et al.
Published: (2025-04-01) -
Co-representation breaks down beyond the dyad in UK adults.
by: Sophie J Milward, et al.
Published: (2025-01-01)